Basel Medical Group (NASDAQ:BMGL) Trading 1.5% Higher – Time to Buy?

Basel Medical Group Ltd (NASDAQ:BMGL)’s share price was up 1.5% during trading on Monday . The company traded as high as $0.6703 and last traded at $0.6432. Approximately 41,958 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 70,156 shares. The stock had previously closed at $0.6337.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Basel Medical Group in a research note on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Basel Medical Group has an average rating of “Sell”.

Basel Medical Group Stock Performance

The stock’s fifty day moving average is $0.95 and its two-hundred day moving average is $1.60.

Basel Medical Group (NASDAQ:BMGL) last released its quarterly earnings results on Monday, November 17th. The company reported ($0.25) EPS for the quarter. The firm had revenue of $2.60 million for the quarter.

Hedge Funds Weigh In On Basel Medical Group

A number of institutional investors have recently added to or reduced their stakes in BMGL. Marex Group plc bought a new stake in shares of Basel Medical Group during the 2nd quarter valued at about $25,000. Vanguard Personalized Indexing Management LLC bought a new position in shares of Basel Medical Group in the third quarter worth approximately $40,000. Virtu Financial LLC raised its stake in Basel Medical Group by 108.8% in the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock valued at $61,000 after purchasing an additional 17,608 shares in the last quarter. Finally, Citadel Advisors LLC purchased a new stake in Basel Medical Group in the third quarter valued at approximately $169,000.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.